Injecting HER2 overexpressing ALDH+ cells into the mammary fat pads of NOD/SCID mice generates tumors with 4-fold more BCSCs than the tumor that developed from ALDH+ cells with normal HER2 expression. This evidence concerns the gene ERBB2 and neoplasm.